A randomized phase II trial of sequential gemcitabine plus vinorelbine followed by gemcitabine plus Ifosfamide versus gemcitabine plus cisplatin in the treatment of chemonaive patients with stage III and IV non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Teodorescu, G
Ciuleanu, T
Grigorescu, A
Firoiu, E
Muresan, DR
机构：
[1] Eli Lilly SRL, Bucharest, Romania
[2] Cluj Oncol Inst, Cluj Napoca, Romania
[3] Bucharest Oncol Inst, Bucharest, Romania
[4] Targoviste Cty Hosp, Targoviste, Romania
[5] Oradea Cty Hosp, Oradea, Romania
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
10.1016/S0169-5002(05)81075-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S271 / S272
页数：2
相关论文
共 50 条
  • [41] A multicenter phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage IIIB/IV) non-small cell lung cancer
    Chen, YM
    Perng, RP
    Yang, KY
    Liu, TW
    Tsai, CM
    Ming-Liu, J
    Whang-Peng, J
    CHEST, 2000, 117 (06) : 1583 - 1589
  • [42] Safety and Resource Utilization by Non-small Cell Lung Cancer Histology Results from the Randomized Phase III Study of Pemetrexed Plus Cisplatin versus Gemcitabine Plus Cisplatin in Chemonaive Patients with Advanced Non-small Cell Lung Cancer
    Novello, Silvia
    Pimentel, Francisco Luis
    Douillard, Jean-Yves
    O'Brien, Mary
    von Pawel, Joachim
    Eckardt, John
    Liepa, Astra M.
    Simms, Lorinda
    Visseren-Grul, Carla
    Paz-Ares, Luis
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (10) : 1602 - 1608
  • [43] Cisplatin plus vinorelbine or gemcitabine in patients with advanced non-small cell lung cancer: Pharmacoeconomic considerations
    Hughes, DA
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (11) : 1655 - 1655
  • [44] Gemcitabine plus cisplatin in advanced non small cell lung cancer (NSCLC)
    Casal, J
    Huidobro, G
    Grande, C
    ANNALS OF ONCOLOGY, 1998, 9 : 103 - 103
  • [45] Correlations of biomarker expression and clinical outcome in a large phase III trial of pemetrexed plus cisplatin or gemcitabine plus cisplatin in chemonaive patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)
    Scagliotti, Giorgio
    Kaiser, Christopher
    Biesma, Bonne
    Manegold, Christian
    Gatzemeier, Ulrich
    Serwatowski, Piotr
    Syrigos, Kostas
    Balint, Beatrix
    Smit, Hans J.
    Vansteenkiste, Johan
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S375 - S375
  • [46] Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: A phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group
    Gridelli, C
    Gallo, C
    Shepherd, FA
    Illiano, A
    Piantedosi, F
    Robbiati, SF
    Manzione, L
    Barbera, S
    Frontini, L
    Veltri, E
    Findlay, B
    Cigolari, S
    Myers, R
    Ianniello, GP
    Gebbia, V
    Gasparini, G
    Fava, S
    Hirsh, V
    Beziak, A
    Seymour, L
    Perrone, F
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (16) : 3025 - 3034
  • [47] A randomized phase II trial of cisplatin plus gemcitabine versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT0703)
    Shin-ichi Fukumoto
    Satoshi Oizumi
    Masao Harada
    Noriaki Sukoh
    Kosuke Nakano
    Satoshi Fuke
    Jun Sakakibara-Konishi
    Kei Takamura
    Kenichiro Ito
    Yuka Fujita
    Yutaka Nishigaki
    Toshiyuki Harada
    Kenji Akie
    Ichiro Kinoshita
    Toraji Amano
    Hiroshi Isobe
    Hirotoshi Dosaka-Akita
    Masaharu Nishimura
    Cancer Chemotherapy and Pharmacology, 2020, 86 : 117 - 127
  • [48] A randomized phase II trial of cisplatin plus gemcitabine versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT0703)
    Fukumoto, Shin-ichi
    Oizumi, Satoshi
    Harada, Masao
    Sukoh, Noriaki
    Nakano, Kosuke
    Fuke, Satoshi
    Sakakibara-Konishi, Jun
    Takamura, Kei
    Ito, Kenichiro
    Fujita, Yuka
    Nishigaki, Yutaka
    Harada, Toshiyuki
    Akie, Kenji
    Kinoshita, Ichiro
    Amano, Toraji
    Isobe, Hiroshi
    Dosaka-Akita, Hirotoshi
    Nishimura, Masaharu
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 86 (01) : 117 - 127
  • [49] A RANDOMIZED PHASE II TRIAL OF CISPLATIN PLUS GEMCITABINE VERSUS CARBOPLATIN PLUS GEMCITABINE IN PATIENTS WITH COMPLETELY RESECTED NON-SMALL CELL LUNG CANCER: HOKKAIDO LUNG CANCER CLINICAL STUDY GROUP TRIAL (HOT0703)
    Harada, T.
    Fukumoto, S.
    Harada, M.
    Nakano, K.
    Sukoh, N.
    Fuke, S.
    Asahina, H.
    Takamura, K.
    Yamamoto, M.
    Fujita, Y.
    Akie, K.
    Kinoshita, I.
    Oizumi, S.
    Akita, H.
    Isobe, H.
    Nishimura, M.
    ANNALS OF ONCOLOGY, 2014, 25
  • [50] Gemcitabine plus vinorelbine in elderly or unfit patients with non-small cell lung cancer
    Beretta, GD
    Michetti, G
    Belometti, MO
    Gritti, G
    Quadri, A
    Poletti, P
    Labianca, R
    BRITISH JOURNAL OF CANCER, 2000, 83 (05) : 573 - 576
12345